A partnership between the Laboratory for Technological Innovation in Health (LAIS/UFRN) and the Atena Institute will allow volunteers who participated in research to test immunizers against covid-19 in Rio Grande do Norte to issue their vaccine passports. The issue will take place through the ADA platform for applied clinical research (click HERE to access the platform), developed by LAIS for this very purpose.

The Atena Institute will be responsible for feeding the ADA platform with data from volunteers who were actually vaccinated with the immunizers tested and authorized by Anvisa. In the cases of volunteers who tested immunizers not yet authorized, they will receive a declaration of participation in the research process, according to the technical note No. 66/2021-SECOVID, issued by the Ministry of Health.

For LAIS executive director, Professor Ricardo Valentim, the ADA platform guarantees all volunteers the right to have their immunization recognized. “In Brazil, more than 60,000 people have volunteered and need to have their immunization against covid-19 registered, with the right to have their vaccine passport,” he warned.

The ADA platform was developed by LAIS in partnership with the Research Center of the Hospital Federal dos Servidores do Estado do Rio de Janeiro. The platform has also been validated by the Brazilian Association of Clinical Research, which brings together more than 40 research centers throughout Brazil.